Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Defibrillator Market: By Product Type, External Defibrillator, By End-user, and Region Forecast 2019-2030
Defibrillators market size was valued at US$ 10.1 billion in 2023 and is expected to reach US$ 12.8 billion by 2030, at a CAGR of 4.6% from 2024-2030. Heart muscles require a continuous supply of blood for proper functioning. When the supply of blood to the artery is decreased cardiac arrhythmias and heart attack may occur. Blockage of the coronary artery may occur due to improper impulse conduction or blood clots. If not treated immediately may lead to death. A defibrillator is used to prevent the sudden cardiac attack. Specially used for ventricular fibrillation and nonperfusion ventricular tachycardia. These conditions occur due to the disruption of normal electrical impulse that controls the heart rate and pumping action.
The defibrillator sends an electrical current to the heart which is used to restart the normal functioning of the heart. Defibrillator treatment is given for patients only when there is a high risk of sudden heart failure or sudden cardiac death. Normally Defibrillators are used for outpatient. Many of heart care associations and alliances are promoting to create awareness about cardiac conditions and increase the survival rate of patients are expected to show significant growth for the market during the forecast period.
For instance, in 2016, the Global Resuscitation Alliance (GRA) was formed comprising of, global resuscitation leaders, international health organizations, and American Heart Association (AHA). The market is very dynamic in nature. The market is dominated by very few players. To enhance their sales revenue companies are inorganic growth strategies such as adopting mergers and acquisitions. In addition, companies are betting heavily on R&D to develop new technologies.
Study Period
2024-2030Base Year
2023CAGR
4.6%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Defibrillator market growth is driven by rapidly growing geriatric patients who are very susceptible to cardiac diseases, technological advancements in defibrillators, growing awareness in sudden cardiac arrest, and increased incidents of cardiac diseases. Two of the most important advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). However, factors such as frequent product recalls, increase in pricing pressure on players, and lack of awareness about sudden cardiac arrest (SCA)
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 10.1 billion |
Market Size in 2030 |
US$ 12.8 billion |
Market CAGR |
4.6% |
By product type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The defibrillator market size was valued at US$ 10.1 billion in 2023 and is set to reach US$ 12.8 billion by 2030 at a CAGR of 4.6%. from 2024-2030
The market key players are: Medtronic (U.S.) Abbott Laboratories (U.S.) Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan) LivaNova PLC (U.K) Physio-Control, Inc. (U.S.) Nihon Kohden Corporation (Japan) BIOTRONIK SE & Co. KG (Germany) Koninklijke Philips N.V. (Netherlands) Boston Scientific Corporation(U.S.)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Defibrillator Market Introduction |
2.1.Global Defibrillator Market - Taxonomy |
2.2.Global Defibrillator Market - Definitions |
2.2.1.Product Type |
2.2.2.End Users |
2.2.3.Region |
3. Global Defibrillator Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Defibrillator Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Defibrillator Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Implantable Cardioverter Defibrillators |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. External Defibrillator |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Defibrillator Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cardiac Clinics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Home Care |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Defibrillator Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Defibrillator Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Implantable Cardioverter Defibrillators |
8.1.2.External Defibrillator |
8.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals |
8.2.2.Cardiac Clinics |
8.2.3.Home Care |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Defibrillator Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Implantable Cardioverter Defibrillators |
9.1.2.External Defibrillator |
9.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Cardiac Clinics |
9.2.3.Home Care |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10. Asia Pacific (APAC) Defibrillator Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Implantable Cardioverter Defibrillators |
10.1.2.External Defibrillator |
10.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Cardiac Clinics |
10.2.3.Home Care |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Defibrillator Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Implantable Cardioverter Defibrillators |
11.1.2.External Defibrillator |
11.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Cardiac Clinics |
11.2.3.Home Care |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Defibrillator Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Implantable Cardioverter Defibrillators |
12.1.2.External Defibrillator |
12.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Cardiac Clinics |
12.2.3.Home Care |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Medtronic (U.S.) |
13.2.2.Abbott Laboratories (U.S.) |
13.2.3.Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan) |
13.2.4.LivaNova PLC (U.K) |
13.2.5.Physio-Control, Inc. (U.S.) |
13.2.6.Nihon Kohden Corporation (Japan) |
13.2.7.BIOTRONIK SE & Co. KG (Germany) |
13.2.8.Koninklijke Philips N.V. (Netherlands) |
13.2.9.Boston Scientific Corporation(U.S.) |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players